Generic selectors
Exact matches only
Search in title
Search in content
Filter by Categories


Intervenn attracts $201m in series C
Intervenn Biosciences was co-founded by faculty members at Stanford University and University of California, Berkeley.
Planted grows with $21m
New and returning investors have chipped into the ETH Zurich plant-based meat spinout’s pre-series B round, five months after it completed a series A.
T-Knife secures $110m in series B
The MDC spinout raised a series B round which will be used to boost its manufacturing capacity and advance its pipeline of candidates.
Everactive tops up series C
The industrial sensor manufacturer spun out of Michigan and Virginia has increased its latest round to $51m in a tranche backed by 3M, Ericsson and Armstrong International.
Daily deal net: July 30, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Deep Genomics jumps into $180m series C
University of Toronto-linked Deep Genomics has picked up $180m in its series C round led by SoftBank Vision Fund 2.
Niron Magnetics attracts $21.3m
University of Minnesota spinout Niron Magnetics has collected $21.3m in funding to build a pilot production facility for its rare earth-free magnets.
IgGenix initiates $25m series A1
Co-founded by Stanford researchers, IgGenix is working on therapies that address severe allergies.

Other News

Isar Aerospace increases series B payload
TU Munich spinout Isar Aerospace has added $75m to its series B round, bringing the round’s total to nearly $166m and its overall financing to more than $183m.
Ring circles $117m series B
UPMC Enterprises has contributed to a $117m series B round for gene therapy developer Ring Therapeutics.
Topas tops up series B
Topas Therapeutics has almost doubled its series B round to $48m thanks to an extension backed by all of its shareholders.
PsiQuantum crosses off $450m in funding
PsiQuantum has become the first unicorn in Imec.xpand’s portfolio as it fetched a valuation of more than $3bn.
Embark passes series B test with $75m
Cornell-linked dog DNA test developer Embark Veterinary raised the capital in a round led by SoftBank Vision Fund 2 at a $700m post-money valuation.
Onera Health wakes up to $12.7m
Imec.xpand has returned to back a series B round for sleep diagnostic developer Onera Health, spun out of Imec.

Editor's Picks

Big deal: Oxford PV begins capturing series D
Goldwind, Legal & General and Equinor have all taken part in a series D that achieved a $41m first close and boosted the Oxford spinout’s total equity and debt to more than $118m.
Big deal: Ribon ties together $65m series B
Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.
Big deal: Ambys arrives at $140m investment
Ambys Medicines has raised $60m in a series A round backed by Takeda and signed a strategic partnership agreement with the corporate worth $80m.
Big deal: QuantumScape fuels up on VW cash
VW will invest $100m in QuantumScape and form a joint venture with the Stanford spinout to develop batteries for long-range electric vehicles.
test reg